due to pipe russian gas to germany the sanctions affect construction of the north stream to pipeline the move is expected to draw an angry response from germany and russia. you're watching news live from berlin up next we've got a documentary film for you on how new ways are being found to fund medical research i'm terry martin thanks for watching. welcome to the book is the game here for d.w.i. . we have plenty to talk about and. let's just come briefly. 3 more please. let's little we have. let's have a look at so many of them are legal so you don't want to miss the. d.w.p. . the

ice bucket challenge in 2014 people all over the world record ice water over their heads in a bid to focus more medical research on the rare motor neuron disease a.l.'s. they posted the videos on social networks and raised millions in private donations scientists took note they'd seen how their laboratories and the public could be just a click apart. what would you rather we didn't. think of dust i think we can now invent new drugs faster i fin and i believe there's so much more that we can deal. with white public support medical researchers can tackle diseases at the pharmaceutical industry overlooks.

in the land of social media cats rule one of their stars is lil bub she looks a bit unique but she was exactly what 2 molecular biologist from berlin were searching for. not be able to under all the secrets. even your. scientists daniel to bring him into our live here in this work for the max planck institute for molecular genetics. and in. one night i was on the internet and this cat documentary came up in my recommendation and since one of the cats they showed was a little bug and they said she has 6 toes which was interesting to me but i've seen that before and then they said the cat's also small because she's got weird bones which means this cat has both a limb out from ation and a bone malformation it's i thought this can't be happening it doesn't come if.

this is precisely the true scientist specialty they deal with hereditary diseases. and it's going to the next day i went to daria and said you have to see this cat you won't believe what she's got of we knew that there are genetic mutations that cause limit from actions and also mutations that cause bone malformations but i've never seen a combination of the 2 so i figured the best thing to do was to sequence that which is our special thought if it was totally amazing that something we normally do in our institute which makes most of our friends yawn was related to something that interests millions of people and you mentioned they set out to decipher the famous catch genome but laboratory analysis is expensive so the 2 researchers moved to make use of little bubs high profile tiny plant of bloomington indiana. who will love. with over 200000 you tube subscribers and 3000000 likes on facebook the feline reaches

a vast number of people. social celebrity we wanted to do a broadway that not only us but kind of get think also. or people a common interest in understanding what is behind the certain features that neither of us. will bubs own or microsoft's he was thrilled for him his cat stardom was never an end in itself. when she started getting favors i mean it's a pretty strict rules we. do is that there should be some sort of positive message attached where there is are you know reached out. 3 it's. the berlin researchers launched a crowdfunding campaign in 2015 crowdfunding draws on the vast number of people using the internet.

the cats fans were able to donate small sums to the crowd funding platform the scientists needed a total of $6500.00 to cover part of the research costs but people donated even more and in the end it brought in over $8200.00. now the real research trip began. so normally what happens you know because. you basically work in the lot for i think 2 or 3 years and then you keep your results and they're not the same then you basically release all your results we can reform the cycle be different experience because 1st you can get engaged socially with the people that theme that actually your research interest and then doing the entire process you can communicate with them. the money for a little bubs genome decryption came together within a month mike sent a sample of the cats blood to berlin abraham and his colleagues captured them out.

meant for the donors. so finally we're sequencing but you know you love. staying in touch with the public was a completely new task for the researchers suddenly they themselves were the focus of an audience but it also gave them an opportunity to make science more transparent. we are trying to understand how how did you know function on how and duration that you know can lead to human to teach. the analysis found that little bug was suffering from an unusual accumulation of genetic mutations. osteo patro cysts a rare bone disease where the bone tissue becomes considerably more dense was the most obvious she also had holly dr lee hence her 6 claws. as humans can be born with surplus fingers and toes as well little buds genome could help

understand these rare hereditary diseases better in the future. as it comes on crowd funding could be a good way to enable research into a particular rare disease because that doesn't happen a lot otherwise funding agencies give a lot of money to medical research but it's often difficult to get money for rare diseases off of me so i'm. crowdfunding as a way of enabling research that might otherwise not happen. but i'm sure the bus hunts he's home edition that nobody has discovered before in the study of the. gun . on information that we have not seen previously before. this ancient. new forms of research funding are particularly needed when no one else is investing

. hardly anyone knows this better than the people at the alliance of chronic rare diseases we're meeting christine i'm going to los. if we're the voice of those affected by red diseases. that affect some 4000000 people in germany alone but few of them suffer from the same rare disease. doesn't on any american terms it's normally a few 1000 people but it can also be only a handful of patients worldwide get. patients like josefina schultz who's 10 years old today she was born with a swellings and a heart defect. her parents went from doctor to doctor but no one to give them an answer it took 18 months to get a diagnosis josefina has a rare genetic disorder williams syndrome but she still has a normal life expectancy when i visit if you're affected by red disease it means

1st and foremost that you have to search parents tell us what an enormous burden it is for them to know that something is wrong with their child and not get an answer as to what it means and where it leads. which is when. the pharmaceutical industry focuses on the development of therapies for common diseases secrets home from the association of research based pharmaceutical companies says this is the right approach. for now nobody is responsible for basic research we have a total of $30000.00 diseases 628000 of them are rare in view of that i think it's obvious that the pharmaceutical industry cannot tackle all diseases at the same time. con kaiden on game con research spending by governments in the pharmaceutical sector has been rising for years their aim is to achieve the e.u.'s lisbon target of 3 percent of gross domestic product germany austria and switzerland together and

. asked about 120000000000 euros in research and development every year. however those affected by rare diseases do not automatically benefit the pharmaceutical industry applies a simple formula. for you i think history class how common or how rare is the disease he is there any basic research that shows how it could be treated. or can and can we expect research into it to pay off at some point. but i think you can find. many people affected by rare diseases a hope for new drugs or gene therapy s but it's a complex process scientists must 1st find and develop an active substance then they tested on animals so as not to endanger humans. these studies alone often take years. and then when all the trials have gone well if you go into

clinical trials that is into research with actual patients initially healthy volunteers will be thinking. of around $10000.00 active substances evaluated in pre-clinical research only about 5 actually get as far as clinical trials active ingredients are tested in 3 faces off and on many thousands of patients and the drug will only be approved if the clinical trial goes off without a hitch despite the whole thing takes about 10 to 13 years and cost several $100000000.00 if you're one of the pharmaceutical companies prefer to invest in projects with high profit expectations rare diseases are not included they're often complex and unprofitable christian among us sees the challenge it is in the us say that congo you know that red is eason's can only be treated in an interdisciplinary and cross sectoral way. that means networking is crucial on this the digital

revolution of course supports us in this. and digital techniques are incredibly good tools. he says middle. but where the market shows no interest the state and now society can step in with donations if necessary. it worked with the ice bucket challenge at least $140000000.00 in donations were collected worldwide and a year later the researchers could actually report a success. they were able to replace the damaged protein ls with a synthetic one in the laboratory thus preventing the death of effect itself but still no sense of the new. we have to be aware that this probably won't happen again in that way and we also have to be aware that the people who made the donations didn't necessarily learn a lot about the disease but learned courage by only enthusiastic celebrities tipping ice cold water over their heads and the following it attracted.

more follow what. how big does the crowd have to be. how many followers as it takes to tackle the thousands of rare diseases why does someone need to stay sick when we have the tools to help. romania or ts found the global aid organization rares or nomics in 2012. it helps patients with rare diseases to finance genome analysis. yes mean from brooklyn and her brother are 2 of them. d.n.a. analysis showed that the siblings had different gene defects that required completely different therapies. it is very important people great to see this is the main reason has over 80 percent agree diseases are known to be genetic in origin. comprehensive health

insurance is a luxury in the us some families have gone bankrupt trying to treat rare diseases. i work directly with families to actually talk to the insurance companies to act ask for insurance coverage and every time your early on they say oh it's experimental this experimental test so we can cover it and we started helping any families that we would offer that as an option if they could not afford that. so we they're also trying to do insurance coverage and that's where we say well we'll help you out printing you're willing to do that. in a company's patients from the crowdfunding campaign through analysis of the results to possible therapies. i've seen just in the past 4 years alone there has been a big increase in interest in rare diseases and in pharma the more research that is

done the more findings you know. associated with disease the more people will be interested in. networking and crowdfunding are useful tools for people suffering from rare diseases. but there's also a need for political oversight. and incentives have now been created at the e.u. level to encourage the pharmaceutical industry to tackle red diseases and also to see the appeal in developing drugs for them and it's and. these incentives for the pharmaceutical industry include simplified approval for seizures and better patent protection at the same time the costs of d.n.a. analysis have fallen dramatically when the human genome project was launched in 1900 it was the 1st time that all 3000000000 base pairs of the human genome have been identified and mapped. the project took 13 years and cost $3000000000.00

today you can have your genome sequenced in a single day for about $1000.00 and the price continues to fall. to the drop in the cost of sequencing means that you can suddenly do anything you can think to do. come to the fortune income. but what impact is having to 1st court the broad public via the internet have on research. what sort of projects stand a chance. it's. we're flying to london where british researchers were the 1st to lay bare the impact of l.s.d. on the brain using modern scans. the proposal was an online crowd pleaser instead of the target of $25000.00 pounds the crowdfunding campaign brought in more than twice as much. guys.

david knott is a psychiatrist at imperial college in london by stabbing brain out of the influence of l.s.d. he wanted to create the 1st precise imaging study of the drug's effects for medical purposes his priority is the treatment of depression. depression is the largest pools of disability in the western world including germany because there's a very good condition starts young continues all one's life and so it's very expensive but we've made so little progress in the last 20 years that most pharmaceutical companies have given up and that means we it's now up to us as scientists and technicians to take up the challenge not is focusing his research on psychoactive substances it's a difficult but he thinks promising field of research. classic antidepressants like

prozac they increase a return in the brain and they protection from stress they dampen down the stress responses so eventually you know you can cope with the stress of life but the psychedelic kind of reset the brain so that you can overcome the stress rather than protect yourself against. the w.h.o. classifies l.s.d. is highly dangerous which means no public funding for research into the substance is available. it is not a medicine there's only one class and that class is the most harmful and once you're in that class it's very hard to work with. the money from the crowd funding camp david complete his imaging study subjects were given l.s.d. and put into the brain scanner with unexpected results. we found exactly the opposite of what we predicted we thought people having a trip on magic mushrooms or as the seeing all sorts of wonderful lights images you

know they're traveling through space and going to magic mountains and things we thought their brain will be activated it's not switched off. because these drugs disconnect you from the outside world you're seeing the inner workings of your mind rather than the constraints is put on your mind. and that's why they work in depression because they switch off the circuit of depression to people write to me every day almost saying can i have the treatment i say no because we're not allowed to give you the treatment because these illegals. further studies are needed but the british medical research council which is responsible for research funding is still skeptical money from the state for research into class a drugs it's unthinkable. there are 2 kinds of harms a drug can do there's a harm the drug can do to the people who use it and the harm that drugs can do to society as a result of people using it. and when you look at societal harms way way above

everything else at the top there and then head or when it's just so psychedelics have no societal harm we may even have benefits if the. research against the mainstream is exhausting because state support programs deliberately and quite rightly contain control mechanisms ethics committees constantly reassess the benefits of the general public and the dangers to the test subjects but david not thinks crowd funding is also important for another reason. he's part of a bigger profile of communicating science and also communicating the obstructions to science that's actually critical because we're in this stupid position of having drugs for 50 years because the traditional media refuse to think differently social media you've got much more opportunities to achieve communicate the truth to people so so i see crowdfunding as part of

a larger public. communication strategy where we get people to understand that their families are being disadvantaged because the law doesn't allow you to leave but. if the state of the pharmaceutical industry don't support it in the crowd really step in and even impact health policy will medical research become like grassroots democracy in the future. but it seems to be more easier to mobilize people for the others the research was a bit different in my case. we're visiting christopher rom stockholm he's also been trying to obtain funding for his research topic 1st from conventional bodies through crowd funding he's a psychiatrist at that carolyn institute and wants to study the treatment of pedophilia. tried in the traditional way. many many times but i was declined all the time the people reading this application maybe some of them have

personal opinions on the topic there is not in my backyard syndrome around this. there are issues nobody wants to know about although there's a real need for action. the overarching aim of the study is to find ways of reducing the number of child sexual abuse is by establishing an evidence based scientifically proven. method to treat adult men with pedophilia disorder some studies in the. adult population one to 3 percent have sexual fantasies and more than children almost one in 10 girls. sexual abuse during childhood and one in 20 boys and in almost 50 percent of the cases it is done by someone with a pedophile it is a wonder. around wants to find out whether a prostate cancer drug can also preventative lee help pedophiles by inhibiting the

body's own to start their own production. looked on the brain functions behind these risk factors hypersexuality. and disturb self-regulation and i saw that all these brain functions had in common that they were partly regulated by testosterone in a way that if you remove the 1st or strong then it would have a beneficial effect on the risk factors after being refused government funding in sweden christopher started a crowd funding campaign on the english web page crowd science in 2016 with everything a campaign like this needs. but i had to find something to give in return in my case of. early results to get to know of the results of the study early and to maybe come here and visit the. post called some t. shirts and think. the outcome was devastating crowd showed little interest and

not even 2500 pounds were raised he needs 38000. but then when i counted the money when i looked on the account. almost nothing came in to sponsor this kind of project maybe people think that i have some kind of personal link to the problem to something that you have been the victim yourself or something like that and most people choose to not because of that i think. ron has now turned his back on crowdfunding for the time being he's recognised that science is facing new challenges. as a researcher you must change your thinking you must you know convince the layman. people are not involved in research at all. it's clear society should not leave decisions to the general public exclusively anymore than it should to the

pharmaceutical industry. some startups are taking a different approach they don't involve the crowd as private donors for a good idea but as participants in an up and coming company. our research leads us to a christian sits in berlin his company is developing a therapy for aids patients. it's not really a self-starter because public perception of aids is that it's now less threatening . but that's wrong the virus is adaptability means it can quickly become resistant to existing drugs. mice medicament and most drugs in the current standard therapy target the building blocks of the virus

itself. our substance attacks the building blocks of the human cell on which the virus inevitably depends. because if you shut down those building blocks the virus can't replicate the new cute kind of feels many people. more than 200 donors have so far invested over 300000 euro in christians it's a start up. and they're hoping to profit from the sale of the company's shares the risk is high but this sort of crowd investment spreads it over a wide investor base. some einen on the one hand it's very difficult to attract larger investors during the early phase which is where we are still. but you do get the chance to let people know that while treatment for hiv is good the virus is still a problem in the uk and probably in the last days. but the crowd doesn't just

provide funding for medical research many projects also call for the bundled knowledge from a community of researchers. really high on top of that. i mean just to. go any. good morning. we're in mumbai india mumbai's location and population density make it a stronghold for transmittable diseases the monsoon in june also brings in mosquitoes 60 percent of the city consists of slums the much loved breeding. around for the mosquito genius enough of these. the females transmit parasites one sucking blood which causes malaria.

the national chemistry laboratory. this is where it. is doing research into anti-malaria drugs. definitely is not strictly population in fact. for example in mumbai in india we do have. to see snow so every year after the monsoon rains here you have. patients coming into hospital with. $200000000.00 new infections worldwide every year malaria is hardly a rare disease nevertheless the development of an effective drug has been sluggish . diseases like you know i think once you become obese then. come.

along and there is a lot of money to be made by. companies because they can see what an extended period of time with the infectious disease. especially for malaria is you know just 2 weeks treatment. the scientists have to deal with the pathogens mutations despite extensive research to fight against. different pathogens from region to region genetic differences in people affected co-infections with other germs and increasing resistance have all conspired to slow the development of a reliable the. seen against malaria. the swiss foundation medicines for malaria venture supports scientists in india and other affected countries working with with scientists from countries that actually

have malaria is really important you always hear in the news that you know there are new mutants coming up with new or even new species arriving but also just to understand is really important. the m.v. foundation distributes important raw materials from malaria research in the form of a malaria kit to dozens of research teams around the world the only condition is that the results must be freely accessible to all similar to open source software that anyone can work on. and everything must remain patent free so that future drugs do not become unnecessarily expensive. this millennium bugs has 400 molecules some of them have the potential to become drugs real drugs. but a lot of science needs to get done and their fundamental level to understand how this money goes for what they're getting so m.b.

is willing to give this money goes to any to search or anywhere in the world free of cost as long as they promise to shatter the data which comes out of their search so $1.00 of the things that a lot of the open source work has done is bring the whole community together with common standards and common lucian. in this case infrastructure is being created in affected countries a couple our research to go ahead independently of endowment funds. the scientists including now produce the expensive molecules themselves which also excel or rates malaria research. a colleague from the singapore university of technology is here on a visit. his research also benefits from the results from india because he can use them without any restrictions so one of the things we try to do we looking at chemical libraries and i didn't fake molecules that can block any of the part of it

and then look at what in the part of it or in the cell that are affected by these small molecules that line of research using that sort of molecules are doing in my laboratory the only possible because of that open access library made available to a monkey. today the results are spreading faster than the pathogen itself. shanmugam is confident. we have discovered these 2 sets of molecules within the millennium box and once we understand how they work what is their target and then we will test whether better states have the ability to become the assistant to these. it's now completely normal for the research team in pony to exchange results with colleagues all over the world. it's a huge cultural change. one of the deep questions is how you train the

next generation of leaders in drug discovery for neglected disease from the countries themselves so there are very very few groups in the world say you know africa in south america. in southeast asia or in india who where you have a leading international scientists working on drug discovery so anything we can do in these projects are very good for that. the fact that the results of network research are open to all excel arrays the increase in knowledge enormously. sometimes patents block independent development. i linda brant works for the american parcel miss foundation its mission is to bring research neglected by industry to market maturity contraceptives for example our founder languorous never was very impressed. with is

a product that. is a device using a gel and actually emptying the rights to the outside. that costs 90000 euro's. vessel chel is a non-hormonal polymer gel that specifically blocks the vast difference and prevents sperm transportation for about 10 years. the principle is comparable to sterilization but can be easily reversed because a 2nd injection can just rinse the gel out again. it's been tested successfully on humans in india for years however the w.h.o. raised concerns and prevented western countries from participating in the study the foundation is now aiming to change that. and that's how.

you get it to market to its core hole. is not. the devil which o. estimates that there are $80000000.00 and want to pregnancies every year but the development of contraceptive methods for men has stalled and not only because of male concerns about the side effects of hormone treatments pharmaceuticals and more to learn this in missouri and how i believe i have got. some promising to. existing one. now products they feel that if they develop that they can keep with the samples that they are. the part of his foundation is now looking for donors to bring the contraceptive to the market well we're seeking is who are socially minded individual investors who may want you know some kind of return on

their nest. how little they are more interested in the social good we've also heard how do you like to come in and finish something so you want to use that 1st as a big project in regard to maybe get into. the study in india will continue in parallel however the product has hardly any chance of entering the western market from there getting approval for new drugs in europe and north america is a very complicated procedure. intentionally so to protect their respective markets . networking is also an advantage in commercial medical research and has made a new type of pharmaceutical company possible one that isn't large and slow but as

many small active cells around the globe currently there are a lot of startups like this so we went to look at one. because it will do if you know about it. because you're right jonathan montague is the managing director of hotspot therapeutics a boston based company the chemist himself lives in berlin and directs employees all over the world from here. by hot spot design and nice when we say that hot spot the sun never sets. and that means our experiments are going on around the clock. the basis of our research approach is an understanding of how nature regular certain proteins. ones. we can design new drugs that mimic these processes. yes and no

one can and which means we can manufacture new drugs for cancer auto immune diseases and other illnesses hashed out on. a computer program displace the protein atoms 3 dimensionally allowing the researchers to move around inside them in search of suitable substances. for sure their computation or chemistry. when our computational chemistry researchers use screening methods to examine millions of substances in a virtual library to find a match for the target protein from stupidity and. it's like an extremely challenging puzzle where many researchers around the world are searching for the right piece. and skiffs. there are disadvantages of course. our scientists have to be very organized to work with so

many different companies scattered around the world. and to my speed. mind for example you have to get up pretty early to do a teleconference with china. and they also have to get used to not carrying out the experiments themselves if you want. personnel in china costs only a quarter of what it would in germany or the u.s. . so can you do 4 times as much with the same money that would be a turbo charger for research. jonathan montague has already gone through results with chinese researchers when colleagues in the u.s. are just pouring their 1st coffee. but what can such a small team achieve. yeah deaf or time like the advantage of a small team is that interpersonal communication is easier and we can have everyone in the same room and the russian sim.

globally scattered and yet still all in one room this flexibility is a boon to medical researchers around the globe. the various approaches are diverse and promising networks laboratories for research and the crowd funding for finance but they're still not universal panacea. it can be very fashionable when you talk about the old computer stuff sequencing the drug discovery stuff is a whole lot more. but they are helping to create new spaces for research outside the precisely demarcated territories of pharmaceutical giants. it really sets off. a program of scientific activities not only one know what to do but many level it is level. and the masses are

crowds wise enough to rally around the right ideas to finance them. i think it's both pros and cons some projects. are this call therefore irrelevant for instance in the tradition process to get funding that can be done thanks to all the anonymous and the most but on the other hand some projects. discarded for good reason by the traditional research funding but this also risks being done . it's not just the content that's changing the researchers themselves also. i have to adapt an intensive exchange with the public is something very new in the laboratory. one really important us big. scientists we need to do. and we need to improve is to be able to explain the

public exactly what we are doing but also that the actual doing of crowdfunding. communicate science to be but even if they don't fund it because it's out there you're advertising your science and the people can choose to i guess maybe less than one in 50 choose to fund but the other 49 here are. medical researchers fighting for media attention hoping to be seen by online crowd funds. and the pharmaceutical industry is watching and waiting. for projects that could still make a profit. they may have inspired people companies to get back into this because now they see there is a treatment. europe

. look unites. what divides. the. traffic. what binds the continent together. answers and stories of plunging a. spotlight on people. even on d. w. . and ultimately affectionately agent but as affectionately as you can.

see. to mayor putin in the middle of his election campaign in the year 2000 a documentary was filmed for russian television the director vitali months and captured much more was to turn the camera back on the cargo and the film secretly chronicled a power grab actually everything was seriously planned structure. featuring thompson morning rolls through the bushes. featuring a lead role like you've never seen before let me be clear with you. so let me let me bitch do the ends justify the means. with mrs starts december 13th on d w. the

big . play. this is news live from berlin heading for a showdown over a controversial gas pipeline business leaders react with syria after u.s. lawmakers approved sanctions against north stream to the u.s. falls a tool of coersion for russia the companies in germany call for countermeasures against the u.s. . also coming off moscow expels to german diplomats the move is linked to the apparent assassination of a former chechen commander in a berlin last summer germany order to russian diplomats to leave the country plus.